Fathom vs MedScout: Real-Time Intel vs Claims Data
MedScout is a med device sales tool built on Medicare claims data, helping reps target physicians by procedure volume and plan territories.
Where MedScout Is the Right Call
- Med device teams whose buyers bill Medicare heavily, where procedure volume predicts revenue
- Territory planning conversations that need claims visualizations reps can read
- Teams selling into surgical and hospital-adjacent specialties
Where It Breaks for Field Teams
- Claims-only intelligence. If a procedure is not billed to Medicare, MedScout does not see it.
- The private-pay aesthetics market, a major device buyer segment, is nearly invisible in claims data.
- No install base verification. It infers opportunity from billing, not from what a practice actually owns.
- No real-time signals. New services, new providers, and lease events surface months late or never.
Fathom vs MedScout, Side by Side
An honest look at where each approach excels, including where MedScout has the advantage.
| Criteria | Fathom | MedScout |
|---|---|---|
| Data source | Real-time web intelligence plus publicly available federal sources | Medicare claims data for physician targeting |
| Coverage | Full private practice and SMB coverage, 48,198 verified US aesthetic practices | Strong on billing physicians, weak on cash-pay practices |
| Update cadence | Real-time, accounts rescore as the market moves | Claims release cycles, months behind reality |
| Rep workflow | Built for reps: scored map, call briefs, next-best-account routing | Claims visualizations and territory planning views |
| Account scoring | Dual Readiness and Opportunity scores from 200+ data points | Procedure volume rankings from claims |
| Pricing model | Engagement-based, built for mid-market budgets | Publicly reported roughly $15,000 to $40,000 per year |
How Fathom Is Different
Real-time signals, not claims lag
Fathom reads the live web plus publicly available federal sources, so a practice that adds a device, hires an injector, or launches a weight loss program shows up when it happens. Claims data arrives months after the buying decision already happened.
Sees cash-pay buyers
Fathom's census covers 48,198 verified US aesthetic practices, a market that runs almost entirely outside Medicare. If any meaningful slice of your revenue comes from private-pay practices, claims-only targeting is flying blind there.
Verified install base
Fathom verifies what devices a practice actually owns, at 95%+ verified accuracy, instead of inferring ownership from procedure codes. Reps walk in knowing the competitive units on site and the likely replacement window.
A system, not a screen
Fathom pairs scoring with generated briefs, territory routing, and an operating layer the whole team works in. Tiger Aesthetics opened 225 net new accounts in Q1 2026 on it, after zero net new the prior year.
Switching from MedScout
Switching from MedScout is straightforward because the motion is the same, only the intelligence gets deeper. Territories and rep assignments carry over. What changes: claims snapshots become live practice profiles, and reps get scored priorities and briefs instead of charts. Historical targeting logic can be recreated inside Fathom's scoring models, which are trained on your product line. Most teams are fully live in weeks, not quarters.
Frequently Asked Questions
Is MedScout cheaper than Fathom?
Publicly reported MedScout pricing runs roughly $15,000 to $40,000 per year. Fathom uses engagement-based pricing scoped per customer, built for mid-market manufacturers. The honest comparison is cost per closed account, where verified data wins.
Does Fathom use claims data at all?
Yes, as one ingredient. Fathom combines publicly available federal databases, including CMS sources, with real-time web intelligence and proprietary compiled datasets. The difference is that claims are a signal, not the whole product.
Which is better for aesthetic device sales?
Fathom, and it is not close. Aesthetics is cash-pay, so claims-only tools miss most of the market. Fathom's census of 48,198 verified US aesthetic practices was built for exactly this buyer, and it is where the platform's first customers sell.
Can MedScout tell me what devices a practice owns?
MedScout infers activity from procedure billing, which suggests volume but not installed equipment. Fathom verifies install base directly, so reps know the competitive units on site before the first visit.
How fast can we move from MedScout to Fathom?
Weeks, not quarters. Fathom deploys white-labeled to your brand with scoring models trained on your product line and ideal buyer profile. Reps keep their territories and start working scored accounts with briefs almost immediately.
See What MedScout Cannot Show You
Get a live scoring of your territory with real-time install base data, practice-level intelligence, and generated sales briefs.